Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Angelucci F.,,Chronic amphetamine treatment reduces NGF and BDNF in the rat brain,2007,European Neuropsychopharmacology,43,10.1016/j.euroneuro.2007.03.002,Italy;Sweden,Article,Milan;Stockholm,0,Journal,2-s2.0-35348859432
Fanous A.,,Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy,2007,Molecular Psychiatry,61,10.1038/sj.mp.4001996,United States;United States;United States,Article,"Washington, D.C.;;Richmond",1,Journal,2-s2.0-34748901204
Sei Y.,,Neuregulin1-induced cell migration is impaired in schizophrenia: Association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms,2007,Molecular Psychiatry,64,10.1038/sj.mp.4001994,United States,Article,Bethesda,1,Journal,2-s2.0-34247582298
Boks M.,,Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia,2007,European Neuropsychopharmacology,68,10.1016/j.euroneuro.2006.12.003,Netherlands,Review,Utrecht,0,Journal,2-s2.0-34447550448
Williams H.,,Is COMT a susceptibility gene for schizophrenia?,2007,Schizophrenia Bulletin,129,10.1093/schbul/sbm019,United Kingdom,Review,Cardiff,1,Journal,2-s2.0-34548021470
Torrey E.,,Antibodies to Toxoplasma gondii in patients with schizophrenia: A meta-analysis,2007,Schizophrenia Bulletin,324,10.1093/schbul/sbl050,United States,Article,Bethesda,1,Journal,2-s2.0-34548032814
Patil S.,,Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial,2007,Nature Medicine,880,10.1038/nm1632,United States;United States,Article,Deerfield;Indianapolis,0,Journal,2-s2.0-34948858402
Hirsch E.,,Phosphoinositide 3-kinases as a common platform for multi-hormone signaling,2007,Journal of Endocrinology,110,10.1677/JOE-07-0097,Italy,Review,Turin,1,Journal,2-s2.0-34547895443
Bellon A.,,New genes associated with schizophrenia in neurite formation: A review of cell culture experiments,2007,Molecular Psychiatry,52,10.1038/sj.mp.4001985,United States,Review,Houston,1,Journal,2-s2.0-34347261359
Norton N.,,Association analysis of AKT1 and schizophrenia in a UK case control sample,2007,Schizophrenia Research,51,10.1016/j.schres.2007.02.006,United Kingdom,Article,Cardiff,0,Journal,2-s2.0-34249312618
Benes F.,,Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars,2007,Proceedings of the National Academy of Sciences of the United States of America,368,10.1073/pnas.0703806104,United States;United States,Article,Belmont;Boston,1,Journal,2-s2.0-34547209903
Gama C.,,Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder,2007,Neuroscience Letters,125,10.1016/j.neulet.2007.04.001,Brazil;Brazil,Article,Porto Alegre;Porto Alegre,0,Journal,2-s2.0-34248663802
Burdick K.,,COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance,2007,Bipolar Disorders,79,10.1111/j.1399-5618.2007.00384.x,United States;United States,Article,New York;New York,0,Journal,2-s2.0-34249902082
Kanazawa T.,,Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder,2007,Psychiatric Genetics,112,10.1097/YPG.0b013e32801da2e2,United States;Japan,Article,San Diego;Takatsuki,0,Journal,2-s2.0-34248154751
Boucher A.,,Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ<sup>9</sup>-tetrahydrocannabinol,2007,Psychopharmacology,142,10.1007/s00213-007-0721-3,France;Australia;Australia,Article,Paris;Sydney;Sydney,0,Journal,2-s2.0-34248175418
DeRosse P.,,Disrupted in Schizophrenia 1 Genotype and Positive Symptoms in Schizophrenia,2007,Biological Psychiatry,63,10.1016/j.biopsych.2006.07.023,United States,Article,New York,0,Journal,2-s2.0-34247569983
Morita Y.,,A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia,2007,Biological Psychiatry,80,10.1016/j.biopsych.2006.07.025,Japan,Article,Okayama,0,Journal,2-s2.0-34247596490
Deng X.,,"Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia",2007,"American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",34,10.1002/ajmg.b.30351,Japan,Article,Fukuoka,0,Journal,2-s2.0-34247326403
Strohmaier J.,,No association between the serine racemase gene (SRR) and schizophrenia in a German case-control sample,2007,Psychiatric Genetics,10,10.1097/YPG.0b013e3280143e43,Germany,Article,Mannheim,0,Journal,2-s2.0-34247163508
Puri V.,,"Fine Mapping by Genetic Association Implicates the Chromosome 1q23.3 Gene UHMK1, Encoding a Serine/Threonine Protein Kinase, as a Novel Schizophrenia Susceptibility Gene",2007,Biological Psychiatry,27,10.1016/j.biopsych.2006.06.014,United Kingdom,Article,London,0,Journal,2-s2.0-33847096690
Reynolds G.,,The neuronal pathology of schizophrenia: Molecules and mechanisms,2007,Biochemical Society Transactions,35,10.1042/BST0350433,United Kingdom,Conference Paper,Belfast,0,Journal,2-s2.0-34247094666
Zintzaras E.,,Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: A meta-analysis,2007,Psychiatric Genetics,50,10.1097/YPG.0b013e32801119da,Greece,Article,Larisa,0,Journal,2-s2.0-34247101730
Guillin O.,,Brain-Derived Neurotrophic Factor in Schizophrenia and Its Relation With Dopamine,2007,International Review of Neurobiology,43,10.1016/S0074-7742(06)78012-6,France,Review,,0,Book Series,2-s2.0-33847393958
Turunen J.A.,,"The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland",2007,Schizophrenia Research,49,10.1016/j.schres.2006.11.028,Finland;Finland,Article,Helsinki;Helsinki,0,Journal,2-s2.0-33847401520
Hennah W.,,"Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1",2007,Human Molecular Genetics,67,10.1093/hmg/ddl462,Finland,Article,Helsinki,1,Journal,2-s2.0-34047152928
Kundakovic M.,,DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes,2007,Molecular Pharmacology,125,10.1124/mol.106.030635,United States,Article,Chicago,0,Journal,2-s2.0-33847111254
McClellan J.,,Schizophrenia: A common disease caused by multiple rare alleles,2007,British Journal of Psychiatry,218,10.1192/bjp.bp.106.025585,United States,Review,Seattle,1,Journal,2-s2.0-33847759937
Hall H.,,Potential genetic variants in schizophrenia: A Bayesian analysis,2007,World Journal of Biological Psychiatry,25,10.1080/15622970600892004,Sweden;Sweden,Article,Stockholm;Uppsala,0,Journal,2-s2.0-33847140919
Ehrenreich H.,,Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin,2007,Molecular Psychiatry,197,10.1038/sj.mp.4001907,Germany,Article,Gottingen,1,Journal,2-s2.0-33846550774
Akhondzadeh S.,,"Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial",2007,Schizophrenia Research,221,10.1016/j.schres.2006.11.016,Iran,Article,Tehran,0,Journal,2-s2.0-33846620518
Schürhoff F.,,Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele,2007,"American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",55,10.1002/ajmg.b.30395,France;France;France,Article,Creteil;Creteil;Creteil,1,Journal,2-s2.0-33846326875
Mortimer A.,,Relationship between estrogen and schizophrenia,2007,Expert Review of Neurotherapeutics,23,10.1586/14737175.7.1.45,United Kingdom,Review,Hull,0,Journal,2-s2.0-33846190228
Gallinat J.,,Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans,2007,Journal of Cognitive Neuroscience,26,10.1162/jocn.2007.19.1.59,Germany;Germany,Article,Berlin;Berlin,0,Journal,2-s2.0-33846191870
Roberts R.,,Schizophrenia in translation: Disrupted in schizophrenia (DISC1): Integrating clinical and basic findings,2007,Schizophrenia Bulletin,41,10.1093/schbul/sbl063,United States,Review,Baltimore,1,Journal,2-s2.0-33845866359
Ehlis A.,,Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders,2007,Neuropsychopharmacology,51,10.1038/sj.npp.1301151,Germany,Article,Wurzburg,1,Journal,2-s2.0-33845706859
Li D.,,Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis,2007,Genetics in Medicine,59,10.1097/01.gim.0000250507.96760.4b,United States;China;China,Review,New York;Shanghai;Shanghai,0,Journal,2-s2.0-33846194535
Nicodemus K.,,"Evidence for statistical epistasis between catechol-O -methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia",2007,Human Genetics,120,10.1007/s00439-006-0257-3,United States;United States,Article,Baltimore;Bethesda,0,Journal,2-s2.0-33846363929
Gothelf D.,,Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome,2007,American Journal of Psychiatry,164,10.1176/ajp.2007.164.4.663,Israel,Article,Petah Tiqwa,0,Journal,2-s2.0-34247503348
Mata I.,,Association between the interleukin-1 receptor antagonist gene and negative symptom improvement during antipsychotic treatment,2006,"American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",17,10.1002/ajmg.b.30405,Spain,Article,Santander,0,Journal,2-s2.0-33845415754
Tochigi M.,,No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population,2006,Schizophrenia Research,25,10.1016/j.schres.2006.07.008,Japan,Article,Tokyo,0,Journal,2-s2.0-33750627829
Hoenicka J.,,C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients,2006,Acta Psychiatrica Scandinavica,28,10.1111/j.1600-0447.2006.00874.x,Spain;Spain,Article,Madrid;Madrid,0,Journal,2-s2.0-33750732291
Shirts B.H.,,"Association study of IL10, IL1β, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: Suggestive association with rs16944 at IL1β",2006,Schizophrenia Research,49,10.1016/j.schres.2006.06.037,United States;United States,Article,Pittsburgh;Pittsburgh,0,Journal,2-s2.0-33750604501
Müller N.,,Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission,2006,Neurotoxicity Research,176,10.1007/BF03033242,Germany,Review,Munich,0,Journal,2-s2.0-34548772356
Hall J.,,A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms,2006,Nature Neuroscience,207,10.1038/nn1795,United Kingdom,Article,Edinburgh,0,Journal,2-s2.0-33845260095
Falkai P.,,Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts,2006,Nervenarzt,6,10.1007/s00115-006-2197-5,Germany,Review,Gottingen,0,Journal,2-s2.0-33750909858
Talbot K.,,Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin,2006,Human Molecular Genetics,126,10.1093/hmg/ddl246,United States,Article,Philadelphia,1,Journal,2-s2.0-33749563041
Li C.H.,,Mutation analysis of DARPP-32 as a candidate gene for schizophrenia,2006,Schizophrenia Research,17,10.1016/j.schres.2006.04.003,Taiwan,Article,Hualien,0,Journal,2-s2.0-33749044748
Liu Y.L.,,No association of G72 and d-amino acid oxidase genes with schizophrenia,2006,Schizophrenia Research,48,10.1016/j.schres.2006.06.020,Taiwan,Article,Zhunan,0,Journal,2-s2.0-33748905941
Walss-Bass C.,,A Novel Missense Mutation in the Transmembrane Domain of Neuregulin 1 is Associated with Schizophrenia,2006,Biological Psychiatry,88,10.1016/j.biopsych.2006.03.017,United States,Article,San Antonio,0,Journal,2-s2.0-33748742622
Goldberg T.,,The G72/G30 gene complex and cognitive abnormalities in schizophrenia,2006,Neuropsychopharmacology,114,10.1038/sj.npp.1301049,United States;United States,Article,New York;Bethesda,1,Journal,2-s2.0-33745949219
Shifman S.,,A complete genetic association scan of the 22q11 deletion region and functional evidence reveal an association between DGCR2 and schizophrenia,2006,Human Genetics,27,10.1007/s00439-006-0195-0,United Kingdom,Article,Oxford,0,Journal,2-s2.0-33746954641
Meyer-Lindenberg A.,,Impact of complex genetic variation in COMT on human brain function,2006,Molecular Psychiatry,256,10.1038/sj.mp.4001860,United States,Article,Bethesda,1,Journal,2-s2.0-33748055408
Akbarian S.,,Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders,2006,Brain Research Reviews,266,10.1016/j.brainresrev.2006.04.001,United States,Review,Worcester,0,Journal,2-s2.0-33747872904
Kirkpatrick B.,,DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex,2006,Journal of Comparative Neurology,94,10.1002/cne.21007,United States;United States,Article,Augusta;Baltimore,0,Journal,2-s2.0-33744985583
Porteous D.,,The Genetics and Biology of Disc1-An Emerging Role in Psychosis and Cognition,2006,Biological Psychiatry,149,10.1016/j.biopsych.2006.04.008,United Kingdom,Review,Edinburgh,0,Journal,2-s2.0-33745712343
Hahn C.G.,,Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia,2006,Nature Medicine,446,10.1038/nm1418,United States,Article,Philadelphia,0,Journal,2-s2.0-33745912772
Li D.,,Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia,2006,Human Molecular Genetics,247,10.1093/hmg/ddl122,China;China,Article,Shanghai;Shanghai,1,Journal,2-s2.0-33745616542
Bajestan S.N.,,Association of AKT1 haplotype with the risk of schizophrenia in Iranian population,2006,"American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",69,10.1002/ajmg.b.30291,Japan,Article,Kagoshima,0,Journal,2-s2.0-33745044532
Hong C.,,Family-based association study between G72/G30 genetic polymorphism and schizophrenia,2006,NeuroReport,22,10.1097/01.wnr.0000224763.61959.26,Taiwan,Article,Taipei,0,Journal,2-s2.0-33745464332
Steen R.,,Brain volume in first-episode schizophrenia: Systematic review and meta-analysis of magnetic resonance imaging studies,2006,British Journal of Psychiatry,593,10.1192/bjp.188.6.510,United States,Review,Chapel Hill,1,Journal,2-s2.0-33744901419
Zhao X.,,Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia,2006,Biological Psychiatry,51,10.1016/j.biopsych.2005.10.023,China;China,Article,Shanghai;Shanghai,0,Journal,2-s2.0-33645329090
Magri C.,,Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV=TR schizophrenia: A pilot case-control association study in an Italian sample,2006,American Journal of Medical Genetics - Neuropsychiatric Genetics,31,10.1002/ajmg.b.30294,Italy,Article,Brescia,0,Journal,2-s2.0-33645985139
Kalkman H.,,The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia,2006,Pharmacology and Therapeutics,83,10.1016/j.pharmthera.2005.10.014,Switzerland,Review,Basel,0,Journal,2-s2.0-32644480629
Lipska B.,,Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs,2006,Human Molecular Genetics,137,10.1093/hmg/ddl040,United States,Article,Bethesda,1,Journal,2-s2.0-33645828206
Brown A.,,Prenatal infection as a risk factor for schizophrenia,2006,Schizophrenia Bulletin,348,10.1093/schbul/sbj052,United States;United States;United States,Article,New York;New York;New York,1,Journal,2-s2.0-33645217100
Schwarz M.J.,,IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia,2006,European Archives of Psychiatry and Clinical Neuroscience,63,10.1007/s00406-005-0603-9,Germany,Article,Munich,0,Journal,2-s2.0-33645046637
Norton N.,,Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia,2006,American Journal of Medical Genetics - Neuropsychiatric Genetics,151,10.1002/ajmg.b.30236,United Kingdom,Article,Cardiff,0,Journal,2-s2.0-30344445643
Sawamura N.,,Disrupted-in-Schizophrenia-1 (DISC1): A key susceptibility factor for major mental illnesses,2006,Annals of the New York Academy of Sciences,28,10.1196/annals.1377.018,Japan;United States,Conference Paper,Tokyo;Baltimore,0,Book Series,2-s2.0-34447540081
Marenco S.,,Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex,2006,American Journal of Psychiatry,42,10.1176/ajp.2006.163.4.740,United States,Article,Bethesda,0,Journal,2-s2.0-85047699824
Babulas V.,,Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia,2006,American Journal of Psychiatry,144,10.1176/ajp.2006.163.5.927,United States,Article,New York,0,Journal,2-s2.0-85047696393
Craddock N.,,Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology,2006,Schizophrenia Bulletin,385,10.1093/schbul/sbj033,United Kingdom,Review,Cardiff,1,Journal,2-s2.0-30344447674
Petryshen T.L.,,Genetic investigation of chromosome 5q GABA<inf>A</inf> receptor subunit genes in schizophrenia,2005,Molecular Psychiatry,89,10.1038/sj.mp.4001739,United States;United States,Article,Boston;Cambridge,1,Journal,2-s2.0-32844460312
Kamiya A.,,A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development,2005,Nature Cell Biology,417,10.1038/ncb1328,Japan;United States,Article,Otsu;Baltimore,0,Journal,2-s2.0-28544453286
Yoshikawa M.,,Acute treatment with morphine augments the expression of serine racemase and D-amino acid oxidase mRNAs in rat brain,2005,European Journal of Pharmacology,15,10.1016/j.ejphar.2005.09.001,Japan,Article,Tokyo,0,Journal,2-s2.0-28044436101
Sobell J.L.,,Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians,2005,American Journal of Medical Genetics - Neuropsychiatric Genetics,41,10.1002/ajmg.b.30221,United States,Article,Los Angeles,0,Journal,2-s2.0-27644517765
Roberts R.,,Synaptic differences in the patch matrix compartments of subjects with schizophrenia: A postmortem ultrastructural study of the striatum,2005,Neurobiology of Disease,25,10.1016/j.nbd.2005.03.015,United States,Article,Baltimore,0,Journal,2-s2.0-26944487622
Lane H.,,"Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: A randomized, double-blind, placebo-controlled study",2005,Archives of General Psychiatry,238,10.1001/archpsyc.62.11.1196,Taiwan,Article,Taichung,1,Journal,2-s2.0-27744529018
Gothelf D.,,COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome,2005,Nature Neuroscience,262,10.1038/nn1572,United States;Israel,Article,Stanford;Ramal Aviv,0,Journal,2-s2.0-27644524899
Cannon T.D.,,"Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory",2005,Archives of General Psychiatry,284,10.1001/archpsyc.62.11.1205,United States,Article,Los Angeles,1,Journal,2-s2.0-27744554247
Svenningsson P.,,DARPP-32 mediates the actions of multiple drugs of abuse,2005,AAPS Journal,119,10.1208/aapsj070235,United States,Article,New York,0,Journal,2-s2.0-30544442928
Zhang F.,,Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia,2005,"Genes, Brain and Behavior",33,10.1111/j.1601-183X.2005.00167.x,United Kingdom,Article,Aberdeen,1,Journal,2-s2.0-26444531847
Papiol S.,,Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene,2005,NeuroImage,38,10.1016/j.neuroimage.2005.05.035,Spain,Article,Barcelona,0,Journal,2-s2.0-24944576122
Bishop J.R.,,Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment,2005,Schizophrenia Research,70,10.1016/j.schres.2005.04.001,United States,Article,Iowa City,0,Journal,2-s2.0-23444450578
Schwab S.G.,,Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of european sib-pair families,2005,Biological Psychiatry,120,10.1016/j.biopsych.2005.05.005,Australia;Germany,Article,Perth;Bonn,0,Journal,2-s2.0-25844437076
Gourion D.,,Age at onset of schizophrenia: Interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants,2005,NeuroReport,48,10.1097/01.wnr.0000175245.58708.6b,France;France,Article,Paris;Paris,0,Journal,2-s2.0-24044488636
Munafò M.R.,,Lack of association of the COMT (Val<sup>158/108</sup> Met) gene and schizophrenia: A meta-analysis of case-control studies,2005,Molecular Psychiatry,226,10.1038/sj.mp.4001664,United Kingdom,Article,Oxford,1,Journal,2-s2.0-23744517092
Yamada K.,,Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels,2005,Biological Psychiatry,132,10.1016/j.biopsych.2005.03.018,Japan,Article,Wako,0,Journal,2-s2.0-20444406392
Callicott J.H.,,Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia,2005,Proceedings of the National Academy of Sciences of the United States of America,428,10.1073/pnas.0500515102,United States,Article,Bethesda,1,Journal,2-s2.0-20844463251
Gu Z.,,Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex,2005,Journal of Neuroscience,182,10.1523/JNEUROSCI.1086-05.2005,United States,Article,Buffalo,1,Journal,2-s2.0-19044365206
Norton N.,,No evidence for association between polymorphism in GRM3 and schizophrenia,2005,BMC Psychiatry,43,10.1186/1471-244X-5-23,United Kingdom,Article,Cardiff,1,Journal,2-s2.0-26844450276
Lundorf M.D.,,Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia,2005,American Journal of Medical Genetics - Neuropsychiatric Genetics,47,10.1002/ajmg.b.30137,Denmark,Article,Aarhus,0,Journal,2-s2.0-20244366232
Dean K.,,Environmental risk factors for psychosis,2005,Dialogues in Clinical Neuroscience,87,,United Kingdom,Review,London,0,Journal,2-s2.0-17444371663
Mulle J.,,No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families,2005,Molecular Psychiatry,36,10.1038/sj.mp.4001619,United States,Article,Baltimore,1,Journal,2-s2.0-18444408669
Sanders A.R.,,Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia,2005,Molecular Psychiatry,50,10.1038/sj.mp.4001586,United States,Article,Evanston,0,Journal,2-s2.0-16844366262
Avguštin B.,,Increased Th<inf>1</inf> and Th<inf>2</inf> immune reactivity with relative Th<inf>2</inf> dominance in patients with acute exacerbation of schizophrenia,2005,Croatian Medical Journal,58,,Slovenia,Article,Ljubljana Polje,0,Journal,2-s2.0-18844454972
Riddle E.L.,,Multi-tasking RGS proteins in the heart: The next therapeutic target?,2005,Circulation Research,98,10.1161/01.RES.0000158287.49872.4e,United States,Review,San Diego,1,Journal,2-s2.0-14844343100
Heresco-Levy U.,,D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia,2005,Biological Psychiatry,289,10.1016/j.biopsych.2004.12.037,Israel;Israel,Article,Jerusalem;Jerusalem,0,Journal,2-s2.0-15444377601
Hayashi M.,,Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1,2005,Proceedings of the National Academy of Sciences of the United States of America,59,10.1073/pnas.0500330102,Brazil,Article,Sao Paulo,1,Journal,2-s2.0-20144374692
Alimohamad H.,,Antipsychotics alter the protein expression levels of β-catenin and GSK-3 in the rat medial prefrontal cortex and striatum,2005,Biological Psychiatry,160,10.1016/j.biopsych.2004.11.036,Canada,Article,London,0,Journal,2-s2.0-14644389398
Staddon S.,,Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population,2005,Schizophrenia Research,37,10.1016/j.schres.2004.06.011,United Kingdom,Article,London,0,Journal,2-s2.0-9644276907
Cordeiro Q.,,Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil,2005,"Genes, Brain and Behavior",48,10.1111/j.1601-183x.2004.00096.x,Brazil,Article,Sao Paulo,1,Journal,2-s2.0-12944316462
Lawford B.,,The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia,2005,Schizophrenia Research,61,10.1016/j.schres.2004.08.020,Australia,Article,Brisbane,0,Journal,2-s2.0-9644272541
Lane H.,,Dopamine D <inf>3</inf> receptor Ser9Gly polymorphism and risperidone response,2005,Journal of Clinical Psychopharmacology,65,10.1097/01.jcp.0000150226.84371.76,Taiwan;Taiwan,Article,Taichung;Taichung,0,Journal,2-s2.0-12344260363
Chen Q.,,A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population,2005,Schizophrenia Research,76,10.1016/j.schres.2004.07.002,China;China,Article,Suzhou;Shanghai,0,Journal,2-s2.0-9644291602
Foltyn V.,,"Serine racemase modulates intracellular D-serine levels through an α,β-elimination activity",2005,Journal of Biological Chemistry,154,10.1074/jbc.M405726200,Israel,Article,Haifa,1,Journal,2-s2.0-19944432442
Millan M.J.,,Dopamine D<inf>3</inf> receptors as a novel target for improving the treatment of schizophrenia,2005,Medecine/Sciences,6,10.1051/medsci/2005214434,France,Review,Neuilly-sur-Seine,1,Journal,2-s2.0-17444420164
Reynolds G.P.,,Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response,2005,European Neuropsychopharmacology,110,10.1016/j.euroneuro.2004.07.001,United Kingdom,Article,Belfast,0,Journal,2-s2.0-13244262700
Tuominen H.,,Glutamatergic drugs for schizophrenia: A systematic review and meta-analysis,2005,Schizophrenia Research,178,10.1016/j.schres.2004.05.005,Finland;Germany,Article,Helsinki;Helsinki,0,Journal,2-s2.0-9244243064
Harrison P.J.,,"Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence",2005,Molecular Psychiatry,1591,10.1038/sj.mp.4001558,United Kingdom;United Kingdom,Review,Oxford;Oxford,1,Journal,2-s2.0-12344327212
Karayiorgou M.,,The molecular genetics of the 22q11-associated schizophrenia,2004,Molecular Brain Research,114,10.1016/j.molbrainres.2004.09.029,United States,Conference Paper,New York,0,Journal,2-s2.0-9744258806
Schurov I.L.,,Expression of disrupted in Schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment,2004,Molecular Psychiatry,141,10.1038/sj.mp.4001574,United Kingdom,Article,Harlow,1,Journal,2-s2.0-11244277000
Hirvonen M.,,C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo [1],2004,Molecular Psychiatry,156,10.1038/sj.mp.4001561,Finland;Finland,Letter,Abo;Turku,1,Journal,2-s2.0-9644283721
Ohtsuki T.,,Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population,2004,Molecular Psychiatry,49,10.1038/sj.mp.4001559,Japan,Article,Tsukuba,1,Journal,2-s2.0-19644400682
Ikeda M.,,Association of AKT1 with schizophrenia confirmed in a Japanese population,2004,Biological Psychiatry,126,10.1016/j.biopsych.2004.07.023,Japan;Japan,Article,Nagoya;Toyoake,0,Journal,2-s2.0-7444272129
Numakawa T.,,"Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia",2004,Human Molecular Genetics,297,10.1093/hmg/ddh280,Japan,Article,Kodaira,1,Journal,2-s2.0-8444250206
Millar J.,,DISC1 and DISC2: Discovering and dissecting molecular mechanisms underlying psychiatric illness,2004,Annals of Medicine,67,10.1080/07853890410033603,United Kingdom;United Kingdom,Review,Edinburgh;Edinburgh,0,Journal,2-s2.0-4544339685
Florian M.,,Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation,2004,Steroids,81,10.1016/j.steroids.2004.05.016,Canada,Article,Montreal,0,Journal,2-s2.0-4644264949
Deng X.,,Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia,2004,BMC Psychiatry,39,10.1186/1471-244X-4-21,Japan,Article,Fukuoka,1,Journal,2-s2.0-12944287763
Korostishevsky M.,,"Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis",2004,Biological Psychiatry,150,10.1016/j.biopsych.2004.04.006,Israel,Article,Tel Aviv-Yafo,0,Journal,2-s2.0-3242755008
Scassellati C.,,"Association study of -1727 A/T, -50 C/T and (CAA)<inf>n</inf> repeat GSK-3β gene polymorphisms with schizophrenia",2004,Neuropsychobiology,36,10.1159/000077936,Italy,Article,Brescia,0,Journal,2-s2.0-2642543937
Weickert C.,,Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain,2004,Archives of General Psychiatry,288,10.1001/archpsyc.61.6.544,United States,Article,Bethesda,1,Journal,2-s2.0-2942590969
Kirov G.,,Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria,2004,Biological Psychiatry,131,10.1016/j.biopsych.2004.01.025,United Kingdom,Article,Cardiff,0,Journal,2-s2.0-2342477899
Miyoshi K.,,DISC1 localizes to the centrosome by binding to kendrin,2004,Biochemical and Biophysical Research Communications,89,10.1016/j.bbrc.2004.03.163,Japan,Article,Okayama,0,Journal,2-s2.0-1942504197
James R.,,Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria,2004,Molecular and Cellular Neuroscience,124,10.1016/j.mcn.2004.01.013,United Kingdom,Article,Edinburgh,0,Journal,2-s2.0-2342539835
Dubertret C.,,The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia,2004,Schizophrenia Research,105,10.1016/S0920-9964(03)00220-2,France;France,Article,Paris;Colombes,0,Journal,2-s2.0-1642523801
Owen M.,,The molecular genetics of schizophrenia: New findings promise new insights,2004,Molecular Psychiatry,269,10.1038/sj.mp.4001444,United Kingdom,Review,Cardiff,1,Journal,2-s2.0-0842329756
Hallmayer J.,,Getting our AKT together in schizophrenia?,2004,Nature Genetics,7,10.1038/ng0204-115,United States,Short Survey,Stanford,1,Journal,2-s2.0-0842267623
Heresco-Levy U.,,Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: A retrospective analysis,2004,Schizophrenia Research,117,10.1016/S0920-9964(03)00129-4,Israel;Israel,Article,Jerusalem;Jerusalem,0,Journal,2-s2.0-0348047434
Emamian E.,,Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia,2004,Nature Genetics,720,10.1038/ng1296,United States;United States,Article,New York;New York,1,Journal,2-s2.0-0842310838
Williams N.,,Support for RGS4 as a susceptibility gene for schizophrenia,2004,Biological Psychiatry,112,10.1016/j.biopsych.2003.11.002,United Kingdom,Article,Cardiff,0,Journal,2-s2.0-12144286093
Bechter K.,,The mild encephalitis-hypothesis - New findings and studies,2004,"Psychiatrische Praxis, Supplement",12,10.1055/s-2004-828428,Germany;Germany,Conference Paper,Gunzburg;Ulm,0,Journal,2-s2.0-11144263152
Austin C.,,"Expression of disrupted-in-schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development",2004,Neuroscience,117,10.1016/j.neuroscience.2003.11.010,United States,Article,Kenilworth,0,Journal,2-s2.0-0442292274
Funke B.,,Association of the DTNBP1 locus with schizophrenia in a U.S. population,2004,American Journal of Human Genetics,137,10.1086/425279,United States,Article,Boston,1,Journal,2-s2.0-6344237686
Brandon N.J.,,Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: Implications for schizophrenia and other major neurological disorders,2004,Molecular and Cellular Neuroscience,195,10.1016/j.mcn.2003.09.009,United Kingdom;United Kingdom,Article,Harlow;Hoddesdon,0,Journal,2-s2.0-10744229990
Sullivan P.,,Schizophrenia as a Complex Trait: Evidence from a Meta-analysis of Twin Studies,2003,Archives of General Psychiatry,1380,10.1001/archpsyc.60.12.1187,United States,Article,Chapel Hill,1,Journal,2-s2.0-0344305525
Glatt S.,,Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia,2003,Molecular Psychiatry,106,10.1038/sj.mp.4001321,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-0242552588
Svenningsson P.,,Diverse Psychotomimetics Act Through a Common Signaling Pathway,2003,Science,260,10.1126/science.1089681,United States,Article,New York,0,Journal,2-s2.0-0344443812
Collier D.A.,,The genetics of schizophrenia: Glutamate not dopamine?,2003,European Journal of Pharmacology,80,10.1016/j.ejphar.2003.08.105,United Kingdom,Conference Paper,London,0,Journal,2-s2.0-0242499301
Winterer G.,,P300 and Genetic Risk for Schizophrenia,2003,Archives of General Psychiatry,85,10.1001/archpsyc.60.11.1158,United States,Article,Bethesda,1,Journal,2-s2.0-0242509953
Gallinat J.,,Association of the G1947A COMT (Val<sup>108/158</sup>Met) gene polymorphism with prefrontal P300 during information processing,2003,Biological Psychiatry,154,10.1016/S0006-3223(02)01973-X,Germany,Article,Berlin,0,Journal,2-s2.0-0038433234
Morris J.,,"DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: Regulation and loss of interaction with mutation",2003,Human Molecular Genetics,318,10.1093/hmg/ddg162,United States,Review,Kenilworth,1,Journal,2-s2.0-0037766786
Glahn D.,,Spatial working memory as an endophenotype for schizophrenia,2003,Biological Psychiatry,215,10.1016/S0006-3223(02)01641-4,United States;United States,Article,Los Angeles;San Antonio,0,Journal,2-s2.0-12244266463
Ozeki Y.,,Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth,2003,Proceedings of the National Academy of Sciences of the United States of America,324,10.1073/pnas.0136913100,Japan,Article,Otsu,1,Journal,2-s2.0-0037422609
Chong S.A.,,Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia,2003,American Journal of Medical Genetics - Neuropsychiatric Genetics,48,10.1002/ajmg.b.10004,Singapore,Article,Singapore City,0,Journal,2-s2.0-0041825283
Miyamoto S.,,Recent advances in the neurobiology of schizophrenia.,2003,Molecular interventions,78,10.1124/mi.3.1.27,Japan,Review,Kawasaki,0,Journal,2-s2.0-2342418435
Fujii Y.,,Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia,2003,Psychiatric Genetics,99,10.1097/01.ypg.0000056682.82896.b0,Japan,Article,Fukuoka,0,Journal,2-s2.0-12444314603
Rudolf S.,,The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro,2002,Neuropsychobiology,23,10.1159/000067807,Germany,Article,Lübeck,0,Journal,2-s2.0-0036974867
De Miranda J.,,Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine,2002,Proceedings of the National Academy of Sciences of the United States of America,172,10.1073/pnas.222421299,Brazil,Article,Rio de Janeiro,1,Journal,2-s2.0-0037195093
Zhang X.,,"Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: Association with psychopathology",2002,Schizophrenia Research,152,10.1016/S0920-9964(01)00296-1,United States;China,Article,New Haven;Beijing,0,Journal,2-s2.0-0036775329
Martí S.,,Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population,2002,"American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",81,10.1002/ajmg.1624,Germany,Article,Bonn,0,Journal,2-s2.0-38149138747
Albert K.,,Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia,2002,Archives of General Psychiatry,139,10.1001/archpsyc.59.8.705,United States;United States,Article,New York;New York,1,Journal,2-s2.0-0036327663
DeLisi L.E.,,A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder,2002,American Journal of Psychiatry,204,10.1176/appi.ajp.159.5.803,Italy;United States;Chile;United States;United States;United Kingdom,Article,Milan;New York;Santiago;San Francisco;New York;Oxford,0,Journal,2-s2.0-0036239387
Badner J.,,Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia,2002,Molecular Psychiatry,655,10.1038/sj.mp.4001012,United States,Article,Chicago,1,Journal,2-s2.0-0036258079
Straub R.,,"Genetic variation in the 6p22.3 Gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia",2002,American Journal of Human Genetics,686,10.1086/341750,United States;United States,Article,Richmond;Richmond,1,Journal,2-s2.0-18444364206
Brazil D.,,Ten years of protein kinase B signalling: A hard Akt to follow,2001,Trends in Biochemical Sciences,980,10.1016/S0968-0004(01)01958-2,Switzerland,Review,Basel,0,Journal,2-s2.0-0035499454
Kozlovsky N.,,Low GSK-3 activity in frontal cortex of schizophrenic patients,2001,Schizophrenia Research,106,10.1016/S0920-9964(00)00174-2,Israel,Article,Beer Sheba,0,Journal,2-s2.0-0035476357
Egan M.,,Effect of COMT Val<sup>108/158</sup> Met genotype on frontal lobe function and risk for schizophrenia,2001,Proceedings of the National Academy of Sciences of the United States of America,2027,10.1073/pnas.111134598,United States,Article,Bethesda,1,Journal,2-s2.0-0035810850
Mirnics K.,,Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia,2001,Molecular Psychiatry,374,10.1038/sj.mp.4000866,United States,Article,Pittsburgh,1,Journal,2-s2.0-0035061298
Dubertret C.,,Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients,2001,Schizophrenia Research,38,10.1016/S0920-9964(00)00085-2,France;France,Article,Colombes;Colombes,0,Journal,2-s2.0-0035870802
Wake K.,,Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-D-aspartate receptor-mediated synaptic transmission in mutant mice lacking D-amino-acid oxidase,2001,Neuroscience Letters,86,10.1016/S0304-3940(00)01658-X,Japan,Article,Shimotsuga District,0,Journal,2-s2.0-0035808617
Snyder S.,,Novel neurotransmitters and their neuropsychiatric relevance,2000,American Journal of Psychiatry,209,10.1176/appi.ajp.157.11.1738,United States,Review,Baltimore,0,Journal,2-s2.0-0033765902
Seeman P.,,"Schizophrenia: More dopamine, more D<inf>2</inf> receptors",2000,Proceedings of the National Academy of Sciences of the United States of America,190,10.1073/pnas.97.14.7673,Canada,Note,Toronto,1,Journal,2-s2.0-0034608741
De Vries L.,,The regulator of G protein signaling family,2000,Annual Review of Pharmacology and Toxicology,483,10.1146/annurev.pharmtox.40.1.235,United States,Review,San Diego,0,Book Series,2-s2.0-0034128414
Schwarz M.,,Decreased levels of soluble intercellular adhesion Molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients,2000,Biological Psychiatry,73,10.1016/S0006-3223(99)00206-1,Germany,Article,Munich,0,Journal,2-s2.0-0034653179
Jönsson E.,,Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia,1999,Schizophrenia Research,64,10.1016/S0920-9964(99)00033-X,Sweden,Article,Stockholm,0,Journal,2-s2.0-13544270775
Wolosker H.,,Serine racemase: A glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission,1999,Proceedings of the National Academy of Sciences of the United States of America,644,10.1073/pnas.96.23.13409,United States;Brazil,Article,Baltimore;Rio de Janeiro,1,Journal,2-s2.0-0033539510
Breen G.,,-141 C Del/Ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population,1999,American Journal of Medical Genetics - Neuropsychiatric Genetics,59,10.1002/(SICI)1096-8628(19990820)88:4<407::AID-AJMG19>3.0.CO;2-3,United Kingdom;United Kingdom,Article,Aberdeen;Aberdeen,0,Journal,2-s2.0-0033588110
Harrison P.J.,,The neuropathology of schizophrenia. A critical review of the data and their interpretation,1999,Brain,1333,10.1093/brain/122.4.593,United Kingdom,Review,Oxford,1,Journal,2-s2.0-0032924127
Tallerico T.,,Dopamine D<inf>2</inf> receptor promoter polymorphism: No association with schizophrenia,1999,Psychiatry Research,36,10.1016/S0165-1781(98)00125-5,Canada,Article,Toronto,0,Journal,2-s2.0-0033593666
Weinberger D.,,Cell biology of the hippocampal formation in schizophrenia,1999,Biological Psychiatry,270,10.1016/S0006-3223(98)00331-X,United States,Review,Bethesda,0,Journal,2-s2.0-0033557735
Kawanishi Y.,,Novel variants in the promoter region of the CREB gene in schizophrenic patients,1999,Journal of Human Genetics,27,10.1007/s100380050196,Japan,Article,Tsukuba,1,Journal,2-s2.0-0032720408
Ohara K.,,Functional polymorphism of -141C Ins/Del in the dopamine D<inf>2</inf> receptor gene promoter and schizophrenia,1998,Psychiatry Research,72,10.1016/S0165-1781(98)00092-4,Japan,Article,Hamamatsu,0,Journal,2-s2.0-0032538921
Stöber G.,,Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: Lack of association with schizophrenia and bipolar affective disorder,1998,Journal of Neural Transmission,65,10.1007/s007020050041,Germany,Article,Wurzburg,0,Journal,2-s2.0-0031937745
Raedler T.,,Schizophrenia as a developmental disorder of the cerebral cortex,1998,Current Opinion in Neurobiology,126,10.1016/S0959-4388(98)80019-6,United States,Article,Bethesda,0,Journal,2-s2.0-0031943325
Arinami T.,,A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia,1997,Human Molecular Genetics,395,10.1093/hmg/6.4.577,Japan,Article,Tsukuba,1,Journal,2-s2.0-0030933979
Kendler K.S.,,"Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample: The National Comorbidity Survey",1996,Archives of General Psychiatry,537,10.1001/archpsyc.1996.01830110060007,United States,Article,Richmond,0,Journal,2-s2.0-0029804219
Akbarian S.,,Gene Expression for Glutamic Acid Decarboxylase is Reduced without Loss of Neurons in Prefrontal Cortex of Schizophrenics,1995,Archives of General Psychiatry,814,10.1001/archpsyc.1995.03950160008002,United States,Article,Irvine,0,Journal,2-s2.0-0028948389
Laurent C.,,No major role for the dopamine D2 receptor ser → Cys<sup>311</sup> mutation in schizophrenia,1994,Psychiatric Genetics,36,10.1097/00041444-199400440-00007,France,Article,Paris,0,Journal,2-s2.0-0028574273
Krystal J.,,"Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses",1994,Archives of General Psychiatry,2406,10.1001/archpsyc.1994.03950030035004,United States;United States,Article,New Haven;,0,Journal,2-s2.0-0028323167
Jakob H.,,Gross and histological criteria for developmental disorders in brains of schizophrenics,1989,Journal of the Royal Society of Medicine,74,10.1177/014107688908200808,Germany,Review,Wiesloch,1,Journal,2-s2.0-0024413488
Johnson J.,,Glycine potentiates the NMDA response in cultured mouse brain neurons,1987,Nature,2516,10.1038/325529a0,France,Article,Paris,0,Journal,2-s2.0-0023091647
Gottesman I.,,A polygenic theory of schizophrenia.,1967,Proceedings of the National Academy of Sciences of the United States of America,378,10.1073/pnas.58.1.199,,Article,,1,Journal,2-s2.0-0014107491
Shulgin A.,,"3-Methoxy-4 5-methylenedioxy amphetamine, a new psychotomimetic agent",1964,Nature,26,10.1038/2011120a0,United States,Article,Midland,0,Journal,2-s2.0-33746810304
